Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial.

Left ventricular (LV) dysfunction c-kit-positive, lineage-negative cardiac stem cells (CSC) improving post-infarction when given to animals. We conducted an experiment phase 1 (Stem Cell Infusion in Patients with ischemic cardiomyopathy [Scipio]) from autologous CSC for the treatment of heart failure due to ischemic heart disease.In trial stage A Scipio, patients with post-infarction LV dysfunction (ejection fraction [EF] ≤ 40%) prior to coronary artery bypass grafting were consecutively enrolled in the treatment and control groups. In stage B, patients were randomly assigned to treatment or control groups in a ratio of 2: 3 by using the block scheme of computer-generated randomization. 1 million autologous CSC given by intracoronary infusion at an average of 113 days (SE 4) after surgery; untreated controls.

Although this study is an open label, echocardiographic analysis did not know the duties of the group. The primary endpoint was a short-term security of CSC and the secondary endpoint was efficacy. A per-protocol analysis were used. This study is registered with ClinicalTrials.gov, number NCT00474461.This study is still in progress. 16 patients were assigned to the treatment group and seven for the control group; no side effects were reported related CSC.

On 14 CSC-treated patients were analyzed, LVEF increased from 30 · 3% (SE 1 · 9) before CSC infusion to 38 · 5% (2 · 8) at 4 months after infusion (p = 0 · 001). In contrast, the seven control patients, as long as the appropriate time interval, LVEF did not change (30 · 1% [2 · 4] at 4 months after CABG vs 30 · 2% [2 · 5] at 8 months after CABG). Importantly, CSC healthful effects are even more pronounced in the first year in eight patients (eg, LVEF increased by 12 · 3 unit ejection fraction [2 · 1] vs baseline, p = 0 · 0007).

In seven patients treated in whom cardiac MRI can be done, infarct size decreased from 32 · 6 g (6 · 3) by 7 · 8 g (1 · 7; 24%) at 4 months (p = 0 · 004) and 9 · 8 g (3 · 5; 30%) at 1 year (p = 0 · 04) .This preliminary results in patients with very encouraging. They suggest that intracoronary infusion of autologous CSC effective in improving LV systolic function and reduced infarct size in patients with heart failure after myocardial infarction, and warrant further, larger, phase 2 studies.University of Louisville Research Foundation and the National Institutes of Health ,

D-Luciferin sodium salt
B8311-200 200 mg
EUR 838.8

D-Luciferin sodium salt
B8311-50 50 mg
EUR 351.6

D-Luciferin (sodium salt)
HY-12591 50mg
EUR 183.6

D-Luciferin, Sodium Salt
7902-100 each
EUR 144

D-Luciferin, Sodium Salt
7902-10G each
EUR 2890.8

D-Luciferin, Sodium Salt
7902-10PK each
EUR 3315.6

D-Luciferin, Sodium Salt
7902-1G each
EUR 424.8

D-Luciferin, Sodium Salt
7902-25G each Ask for price

D-Luciferin, Sodium Salt
7902-3PK each
EUR 1110

D-Luciferin, Sodium Salt
7902-50G each Ask for price

D-Luciferin, Sodium Salt
7902-5PK each
EUR 1795.2

D-Luciferin, Potassium Salt
D0510-010 100mg
EUR 222

D-Luciferin, Potassium Salt
D0510-050 500mg
EUR 604.8

D-Luciferin, Potassium Salt
D0510-100 1g
EUR 1016.4

D-Luciferin, potassium salt
10101 10MG
EUR 134.4
Description: Minimum order quantity: 1 unit of 10MG

D-Luciferin, potassium salt
10101-1 50MG
EUR 280.8
Description: Minimum order quantity: 1 unit of 50MG

D-Luciferin, potassium salt
10101-2 1G
EUR 856.8
Description: Minimum order quantity: 1 unit of 1G

D-Luciferin potassium salt
HY-12591B 50mg
EUR 183.6

D-Luciferin, Potassium Salt
7903-100 each
EUR 144

D-Luciferin, Potassium Salt
7903-10G each
EUR 2890.8

D-Luciferin, Potassium Salt
7903-10PK each
EUR 3315.6

D-Luciferin, Potassium Salt
7903-1G each
EUR 424.8

D-Luciferin, Potassium Salt
7903-25G each Ask for price

D-Luciferin, Potassium Salt
7903-3PK each
EUR 1110

D-Luciferin, Potassium Salt
7903-50G each Ask for price

D-Luciferin, Potassium Salt
7903-5PK each
EUR 1795.2

D-Luciferin, sodium salt *CAS#: 103404-75-7*
12509 25 mg
EUR 138

D-Luciferin, sodium salt *CAS#: 103404-75-7*
12510 100 mg
EUR 158.4

D-Luciferin, sodium salt *CAS#: 103404-75-7*
12511 1 g
EUR 633.6

CoviDrop SARS-CoV-2 Spike-ACE2 Binding Inhibitor Screening Fast Kit
D-1004
  • EUR 335.50
  • EUR 576.40
  • 48 Assays
  • 96 Assays

CoviDrop SARS-CoV-2 Spike-ACE2 Binding Activity/Inhibition Assay Kit
D-1005
  • EUR 328.90
  • EUR 564.30
  • 48 Assays
  • 96 Assays

CoviDrop SARS-CoV-2 Targeted Proprotein Convertase Inhibitor Screening Fast Kit
D-1006
  • EUR 353.10
  • EUR 588.50
  • 48 Assays
  • 96 Assays

CoviDrop SARS-CoV-2 Targeted Proprotein Convertase Activity/Inhibition Assay Kit
D-1007
  • EUR 353.10
  • EUR 588.50
  • 48 Assays
  • 96 Assays

SeroFlash SARS-CoV-2 Neutralizing Antibody Assay Fast Kit
D-1008
  • EUR 359.70
  • EUR 570.90
  • 48 Assays
  • 96 Assays

CoviDrop SARS-CoV-2 Specific Furin Cleavage Site (Wild Type) Blocker/Inhibitor Screening Kit
D-1009
  • EUR 456.50
  • EUR 799.70
  • 96 Assays
  • 2x 96 Assays

CoviDrop SARS-CoV-2 Specific Furin Cleavage Site (P681R Mutation) blocker/Inhibitor Screening Kit
D-1010
  • EUR 456.50
  • EUR 799.70
  • 96 Assays
  • 2x 96 Assays

EZSolution? D-Luciferin, Potassium Salt
B3001-set each
EUR 444

Brite-Light? D-Luciferin, Potassium Salt
B3000-10PK each
EUR 2721.6

Brite-Light? D-Luciferin, Potassium Salt
B3000-1G each
EUR 392.4

Brite-Light? D-Luciferin, Potassium Salt
B3000-5PK each
EUR 1560

D-Luciferin
B6040-10 10 mg
EUR 157.2
Description: D-luciferin is a cell-permeable chemiluminescent luciferase substrate with a Km of approximately 2 ?M. D-luciferin could emit lights upon oxidative decarboxylation in the presence of ATP.

D-Luciferin
B6040-200 200 mg
EUR 838.8
Description: D-luciferin is a cell-permeable chemiluminescent luciferase substrate with a Km of approximately 2 ?M. D-luciferin could emit lights upon oxidative decarboxylation in the presence of ATP.

D-Luciferin
B6040-50 50 mg
EUR 351.6
Description: D-luciferin is a cell-permeable chemiluminescent luciferase substrate with a Km of approximately 2 ?M. D-luciferin could emit lights upon oxidative decarboxylation in the presence of ATP.

D-Luciferin
GP9319-100MG 100 mg
EUR 265.2

D-Luciferin
GP9319-10MG 10 mg
EUR 84

D-Luciferin
GP9319-25MG 25 mg
EUR 132

D-Luciferin
GP9319-50MG 50 mg
EUR 180

D-Luciferin
HY-12591A 10mg
EUR 129.6

D-Luciferin, potassium salt *CAS#: 115144-35-9*
12505 25 mg
EUR 138

D-Luciferin, potassium salt *CAS#: 115144-35-9*
12506 100 mg
EUR 158.4

D-Luciferin, potassium salt *CAS#: 115144-35-9*
12507 1 g
EUR 315.6

D-Luciferin acetate
12516 5 mg
EUR 262.8

Estradiol 17-(?-D-Glucuronide) (sodium salt)
C3840-10 10 mg
EUR 247.2
Description: Km: 75 ?MEstradiol 17-(?-D-Glucuronide) is a substrate of the multidrug resistance protein 2 (MRP2).MRP2 is a member of the superfamily of ATP-binding cassette (ABC) transporters, which transport various molecules across extra- and intra-cellular membranes.

Estradiol 17-(?-D-Glucuronide) (sodium salt)
C3840-25 25 mg
EUR 405.6
Description: Km: 75 ?MEstradiol 17-(?-D-Glucuronide) is a substrate of the multidrug resistance protein 2 (MRP2).MRP2 is a member of the superfamily of ATP-binding cassette (ABC) transporters, which transport various molecules across extra- and intra-cellular membranes.

Estradiol 17-(?-D-Glucuronide) (sodium salt)
C3840-5 5 mg
EUR 158.4
Description: Km: 75 ?MEstradiol 17-(?-D-Glucuronide) is a substrate of the multidrug resistance protein 2 (MRP2).MRP2 is a member of the superfamily of ATP-binding cassette (ABC) transporters, which transport various molecules across extra- and intra-cellular membranes.

Estradiol 17-(?-D-Glucuronide) (sodium salt)
C3840-50 50 mg
EUR 602.4
Description: Km: 75 ?MEstradiol 17-(?-D-Glucuronide) is a substrate of the multidrug resistance protein 2 (MRP2).MRP2 is a member of the superfamily of ATP-binding cassette (ABC) transporters, which transport various molecules across extra- and intra-cellular membranes.

Estradiol 3-(?-D-Glucuronide) (sodium salt)
C3897-1 1 mg
EUR 141.6
Description: ?-estradiol 3-(?-d-glucuronide) (E23G) is a noncholestatic regioisomer of the estrogen metabolite, E217G (?-Estradiol 17-(?-d-glucuronide)) [1]. E23G functions as a substrate for multidrug resistance associated protein 2 (MRP2) [2].

Estradiol 3-(?-D-Glucuronide) (sodium salt)
C3897-10 10 mg
EUR 632.4
Description: ?-estradiol 3-(?-d-glucuronide) (E23G) is a noncholestatic regioisomer of the estrogen metabolite, E217G (?-Estradiol 17-(?-d-glucuronide)) [1]. E23G functions as a substrate for multidrug resistance associated protein 2 (MRP2) [2].

Estradiol 3-(?-D-Glucuronide) (sodium salt)
C3897-25 25 mg
EUR 1287.6
Description: ?-estradiol 3-(?-d-glucuronide) (E23G) is a noncholestatic regioisomer of the estrogen metabolite, E217G (?-Estradiol 17-(?-d-glucuronide)) [1]. E23G functions as a substrate for multidrug resistance associated protein 2 (MRP2) [2].

Estradiol 3-(?-D-Glucuronide) (sodium salt)
C3897-5 5 mg
EUR 367.2
Description: ?-estradiol 3-(?-d-glucuronide) (E23G) is a noncholestatic regioisomer of the estrogen metabolite, E217G (?-Estradiol 17-(?-d-glucuronide)) [1]. E23G functions as a substrate for multidrug resistance associated protein 2 (MRP2) [2].

D-Glucuronic acid, sodium salt, monohydrate
GB0483 5g
EUR 128.9

Methyl beta-D-glucuronide sodium salt
GC4190-1G 1 g
EUR 274.8

Methyl beta-D-glucuronide sodium salt
GC4190-250MG 250 mg
EUR 132

D-Glucuronic acid sodium salt monohydrate
GC8431-100G 100 g
EUR 151.2

D-Glucuronic acid sodium salt monohydrate
GC8431-250G 250 g
EUR 274.8

D-Glucuronic acid sodium salt monohydrate
GC8431-25G 25 g
EUR 84

D-Glucuronic acid sodium salt monohydrate
GC8431-5G 5 g
EUR 55.2

D-Glucosamine 2-sulfate sodium salt
GC9126-25MG 25 mg
EUR 73.2

D-Luciferin, free acid
10100 10MG
EUR 134.4
Description: Minimum order quantity: 1 unit of 10MG

D-Luciferin, free acid
10100-1 50MG
EUR 280.8
Description: Minimum order quantity: 1 unit of 50MG

D-Luciferin, free acid
10100-2 1G
EUR 856.8
Description: Minimum order quantity: 1 unit of 1G

D-Luciferin (Free acid)
2779-1000 each
EUR 405.6

D-Luciferin (Free acid)
2779-250 each
EUR 210

D-Luciferin (Free acid)
2779-500 each
EUR 301.2

D-Luciferin (Free acid)
2779-5000 each
EUR 1527.6

CAPS, sodium salt
CB0097 50g
EUR 86.1

CAPSO, sodium salt
CD0041 50g
EUR 91.32

Hepes, Sodium Salt
CH039 25 g
EUR 141.6

Hepes, Sodium Salt
CH040 100 g
EUR 202.8

Hepes, Sodium Salt
CH041 500 g
EUR 448.8

Cefamandole sodium salt
C079-100MG 100 mg
EUR 177.6

Cefamandole sodium salt
C079-500MG 500 mg
EUR 568.8

Ampicillin, Sodium Salt
A4004-005 5g
EUR 111.6

Ampicillin, Sodium Salt
A4004-025 25g
EUR 206.4

Ampicillin, Sodium Salt
A4004-100 100g
EUR 370.8

Narasin (sodium salt)
C3061-25 25 mg
EUR 804
Description: IC50: 3.2 ?M: blocks NF-?B signaling via inhibition of I?B? phosphorylationNarasin, isolated from certain Streptomyces sp. is an ionophore antibiotic.

Narasin (sodium salt)
C3061-5 5 mg
EUR 224.4
Description: IC50: 3.2 ?M: blocks NF-?B signaling via inhibition of I?B? phosphorylationNarasin, isolated from certain Streptomyces sp. is an ionophore antibiotic.

Methicillin (sodium salt)
C3238-100 100 mg
EUR 174
Description: Methicillin is a semisynthetic penicillin antibiotic.In vitro: Similar to other ?-lactam antibiotics, meticillin acts via inhibiting the synthesis of bacterial cell walls.

Methicillin (sodium salt)
C3238-250 250 mg
EUR 271.2
Description: Methicillin is a semisynthetic penicillin antibiotic.In vitro: Similar to other ?-lactam antibiotics, meticillin acts via inhibiting the synthesis of bacterial cell walls.

Methicillin (sodium salt)
C3238-5.1 10 mM (in 1mL DMSO)
EUR 135.6
Description: Methicillin is a semisynthetic penicillin antibiotic.In vitro: Similar to other ?-lactam antibiotics, meticillin acts via inhibiting the synthesis of bacterial cell walls.

Methicillin (sodium salt)
C3238-50 50 mg
EUR 129.6
Description: Methicillin is a semisynthetic penicillin antibiotic.In vitro: Similar to other ?-lactam antibiotics, meticillin acts via inhibiting the synthesis of bacterial cell walls.

Ertapenem (sodium salt)
C3451-10 10 mg
EUR 289.2
Description: Ertapenem, the first group of carbapenems, is a 1-?-methyl carbapenem with potent in vitro activity against a broad spectrum of bacterial pathogens including Gram-positive and Gram-negative aerobic and anaerobic pathogens [1].

Ertapenem (sodium salt)
C3451-25 25 mg
EUR 537.6
Description: Ertapenem, the first group of carbapenems, is a 1-?-methyl carbapenem with potent in vitro activity against a broad spectrum of bacterial pathogens including Gram-positive and Gram-negative aerobic and anaerobic pathogens [1].

Ertapenem (sodium salt)
C3451-5 5 mg
EUR 195.6
Description: Ertapenem, the first group of carbapenems, is a 1-?-methyl carbapenem with potent in vitro activity against a broad spectrum of bacterial pathogens including Gram-positive and Gram-negative aerobic and anaerobic pathogens [1].

Cefoxitin (sodium salt)
C4849-1000 1 g
EUR 289.2
Description: Cefoxitin (sodium salt) is a second generation cephalosporin antibiotic that was used to treat a wide range of gram-negative and gram-positive bacteria [1][2].

Cefoxitin (sodium salt)
C4849-250 250 mg
EUR 135.6
Description: Cefoxitin (sodium salt) is a second generation cephalosporin antibiotic that was used to treat a wide range of gram-negative and gram-positive bacteria [1][2].

Cefoxitin (sodium salt)
C4849-500 500 mg
EUR 196.8
Description: Cefoxitin (sodium salt) is a second generation cephalosporin antibiotic that was used to treat a wide range of gram-negative and gram-positive bacteria [1][2].

Fosmidomycin (sodium salt)
C4898-10 10 mg
EUR 498
Description: Fosmidomycin is a specific inhibitor of 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXP) [1]. Fosmidomycin is an antibiotic originally isolated from bacteria of the genus Streptomyces.

Fosmidomycin (sodium salt)
C4898-25 25 mg
EUR 996
Description: Fosmidomycin is a specific inhibitor of 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXP) [1]. Fosmidomycin is an antibiotic originally isolated from bacteria of the genus Streptomyces.

Fosmidomycin (sodium salt)
C4898-5 5 mg
EUR 292.8
Description: Fosmidomycin is a specific inhibitor of 1-deoxy-d-xylulose 5-phosphate reductoisomerase (DXP) [1]. Fosmidomycin is an antibiotic originally isolated from bacteria of the genus Streptomyces.

Cefsulodin (sodium salt)
C5593-1000 1 g
EUR 268.8
Description: Cefsulodin, formerly named as SCE-129, is a cephalosporin with a spectrum of antibacterial activity against Staphylococcus aureus, Pseudomonas aeruginosa, and most other gram-positive cocci [1].

Cefsulodin (sodium salt)
C5593-250 250 mg
EUR 147.6
Description: Cefsulodin, formerly named as SCE-129, is a cephalosporin with a spectrum of antibacterial activity against Staphylococcus aureus, Pseudomonas aeruginosa, and most other gram-positive cocci [1].

Cefsulodin (sodium salt)
C5593-500 500 mg
EUR 216
Description: Cefsulodin, formerly named as SCE-129, is a cephalosporin with a spectrum of antibacterial activity against Staphylococcus aureus, Pseudomonas aeruginosa, and most other gram-positive cocci [1].

Furegrelate (sodium salt)
C5692-10 10 mg
EUR 204
Description: Furegrelate (sodium salt) is a potent inhibitor of thromboxane synthase [1][2].Thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) is a cytochrome P450 enzyme that catalyzes the conversion of prostaglandin H2 to thromboxane A2.

Furegrelate (sodium salt)
C5692-5 5 mg
EUR 134.4
Description: Furegrelate (sodium salt) is a potent inhibitor of thromboxane synthase [1][2].Thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) is a cytochrome P450 enzyme that catalyzes the conversion of prostaglandin H2 to thromboxane A2.

Furegrelate (sodium salt)
C5692-50 50 mg
EUR 661.2
Description: Furegrelate (sodium salt) is a potent inhibitor of thromboxane synthase [1][2].Thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) is a cytochrome P450 enzyme that catalyzes the conversion of prostaglandin H2 to thromboxane A2.

Ampicillin Sodium Salt
AK0839-0010 10g Ask for price

Ampicillin Sodium Salt
AK0839-0025 25g Ask for price

Ampicillin Sodium Salt
AK0839-0100 100g Ask for price

Heparin Sodium Salt
AK3004-1000 1g Ask for price

Heparin Sodium Salt
AK3004-5000 5g Ask for price

Simvastatin (sodium salt)
C4426-100 100 mg
EUR 470.4
Description: Ki: 0.12 nMSimvastatin is a HMG-CoA reductase inhibitor. HMG-CoA reductase has been found to be the rate-limiting enzyme in the cholesterol biosynthetic pathway and the target of the ?statin? class of cholesterol-lowering drugs.

Simvastatin (sodium salt)
C4426-25 25 mg
EUR 235.2
Description: Ki: 0.12 nMSimvastatin is a HMG-CoA reductase inhibitor. HMG-CoA reductase has been found to be the rate-limiting enzyme in the cholesterol biosynthetic pathway and the target of the ?statin? class of cholesterol-lowering drugs.

Moniliformin (sodium salt)
C4459-1 1 mg
EUR 385.2
Description: Moniliformin induces mitotic arrest at the metaphase stage.Mitosis is a part of the cell cycle when replicated chromosomes are separated into two new nuclei.

Cefotaxime (sodium salt)
C4588-1000 1 g
EUR 151.2
Description: MIC: <0.1 ?g/ml for S. pneumoniae Cefotaxime is a cephalosporin antibiotic.

Cefotaxime (sodium salt)
C4588-5.1 10 mM (in 1mL DMSO)
EUR 135.6
Description: MIC: <0.1 ?g/ml for S. pneumoniae Cefotaxime is a cephalosporin antibiotic.

Cefotaxime (sodium salt)
C4588-500 500 mg
EUR 129.6
Description: MIC: <0.1 ?g/ml for S. pneumoniae Cefotaxime is a cephalosporin antibiotic.

Cefotaxime (sodium salt)
C4588-5000 5 g
EUR 181.2
Description: MIC: <0.1 ?g/ml for S. pneumoniae Cefotaxime is a cephalosporin antibiotic.

Lorglumide (sodium salt)
C4809-25 25 mg
EUR 174
Description: Lorglumide (sodium salt) is the first nonpeptidic, selective and potent inhibitor of the CCK-A receptor [1][2][3][4] .

Lorglumide (sodium salt)
C4809-50 50 mg
EUR 205.2
Description: Lorglumide (sodium salt) is the first nonpeptidic, selective and potent inhibitor of the CCK-A receptor [1][2][3][4] .

Cefamandole (sodium salt)
C3541-100 100 mg
EUR 292.8
Description: MIC: 0.25-2 mg/L for different E. coli strainsCefamandole is a cephalosporin antibiotic.The cephalosporins are a class of ?-lactam antibiotics originally derived from the fungus Acremonium, which was previously known as "Cephalosporium".

Cefamandole (sodium salt)
C3541-50 50 mg
EUR 182.4
Description: MIC: 0.25-2 mg/L for different E. coli strainsCefamandole is a cephalosporin antibiotic.The cephalosporins are a class of ?-lactam antibiotics originally derived from the fungus Acremonium, which was previously known as "Cephalosporium".

Cefamandole (sodium salt)
C3541-500 500 mg
EUR 710.4
Description: MIC: 0.25-2 mg/L for different E. coli strainsCefamandole is a cephalosporin antibiotic.The cephalosporins are a class of ?-lactam antibiotics originally derived from the fungus Acremonium, which was previously known as "Cephalosporium".

Cefonicid (sodium salt)
C3812-1000 1 g
EUR 487.2
Description: Cefonicid is a second-generation cephalosporin antibiotic.Cephalosporins, the largest and most diverse family of antibiotics of the beta-lactam group, are structurally and pharmacologically related to the penicillins.

Cefonicid (sodium salt)
C3812-5.1 10 mM (in 1mL DMSO)
EUR 135.6
Description: Cefonicid is a second-generation cephalosporin antibiotic.Cephalosporins, the largest and most diverse family of antibiotics of the beta-lactam group, are structurally and pharmacologically related to the penicillins.

Cefonicid (sodium salt)
C3812-500 500 mg
EUR 301.2
Description: Cefonicid is a second-generation cephalosporin antibiotic.Cephalosporins, the largest and most diverse family of antibiotics of the beta-lactam group, are structurally and pharmacologically related to the penicillins.

Cefoperazone (sodium salt)
C3913-10000 10 g
EUR 483.6
Description: Cefoperazone is a new semisynthetic cephalosporin with a broad spectrum of antibacterial activity. Cefoperazone shows high activity against gram-positive bacteria and gram-negative bacilli, such as Escherichia coli, Klebsiella pneumoniae, and Proteus species [1].

Cefoperazone (sodium salt)
C3913-5000 5 g
EUR 320.4
Description: Cefoperazone is a new semisynthetic cephalosporin with a broad spectrum of antibacterial activity. Cefoperazone shows high activity against gram-positive bacteria and gram-negative bacilli, such as Escherichia coli, Klebsiella pneumoniae, and Proteus species [1].

Moxalactam (sodium salt)
C4121-1000 1 g
EUR 270
Description: Moxalactam (sodium salt) is a ?-lactam antibiotic.?-lactam antibiotics (beta-lactam antibiotics) are a class of broad-spectrum antibiotics that contain a beta-lactam ring in their molecular structures. Most ?-lactam antibiotics act by inhibiting cell wall biosynthesis.

Moxalactam (sodium salt)
C4121-250 250 mg
EUR 134.4
Description: Moxalactam (sodium salt) is a ?-lactam antibiotic.?-lactam antibiotics (beta-lactam antibiotics) are a class of broad-spectrum antibiotics that contain a beta-lactam ring in their molecular structures. Most ?-lactam antibiotics act by inhibiting cell wall biosynthesis.

Moxalactam (sodium salt)
C4121-5.1 10 mM (in 1mL DMSO)
EUR 135.6
Description: Moxalactam (sodium salt) is a ?-lactam antibiotic.?-lactam antibiotics (beta-lactam antibiotics) are a class of broad-spectrum antibiotics that contain a beta-lactam ring in their molecular structures. Most ?-lactam antibiotics act by inhibiting cell wall biosynthesis.

Moxalactam (sodium salt)
C4121-500 500 mg
EUR 201.6
Description: Moxalactam (sodium salt) is a ?-lactam antibiotic.?-lactam antibiotics (beta-lactam antibiotics) are a class of broad-spectrum antibiotics that contain a beta-lactam ring in their molecular structures. Most ?-lactam antibiotics act by inhibiting cell wall biosynthesis.

Cefazolin (sodium salt)
C4183-1000 1 g
EUR 201.6
Description: Cefazolin is a semisynthetic antibiotic with a broad spectrum of antibacterial activity. Cefazolin has exhibited high activity against Gram-positive bacteria and Gram-negative bacteria [1].

Cefazolin (sodium salt)
C4183-250 250 mg
EUR 126
Description: Cefazolin is a semisynthetic antibiotic with a broad spectrum of antibacterial activity. Cefazolin has exhibited high activity against Gram-positive bacteria and Gram-negative bacteria [1].

Cefazolin (sodium salt)
C4183-5.1 10 mM (in 1mL DMSO)
EUR 135.6
Description: Cefazolin is a semisynthetic antibiotic with a broad spectrum of antibacterial activity. Cefazolin has exhibited high activity against Gram-positive bacteria and Gram-negative bacteria [1].

Cefazolin (sodium salt)
C4183-500 500 mg
EUR 165.6
Description: Cefazolin is a semisynthetic antibiotic with a broad spectrum of antibacterial activity. Cefazolin has exhibited high activity against Gram-positive bacteria and Gram-negative bacteria [1].

Tazobactam (sodium salt)
C4245-1000 1 g
EUR 271.2
Description: Tazobactam is a ?-lactamase inhibitor [1]. Tazobactam shows intrinsic activity against Acinetobacter strains. The ?-Lactamases are responsible for resistance to penicillins, extended-spectrum cephalosporins, monobactams, and carbapenems.

Tazobactam (sodium salt)
C4245-250 250 mg
EUR 139.2
Description: Tazobactam is a ?-lactamase inhibitor [1]. Tazobactam shows intrinsic activity against Acinetobacter strains. The ?-Lactamases are responsible for resistance to penicillins, extended-spectrum cephalosporins, monobactams, and carbapenems.

Tazobactam (sodium salt)
C4245-500 500 mg
EUR 201.6
Description: Tazobactam is a ?-lactamase inhibitor [1]. Tazobactam shows intrinsic activity against Acinetobacter strains. The ?-Lactamases are responsible for resistance to penicillins, extended-spectrum cephalosporins, monobactams, and carbapenems.

Thyroxine (Sodium salt)
30-AT52 1 gram
EUR 422.4
Description: High purity Thyroxine sodium salt

Triiodothyronine (Sodium salt)
30-AT53 1 gram
EUR 1018.8
Description: High purity (>99%) Triiodothyronine sodium salt

Cefotaxime Sodium Salt
20-abx082178
  • EUR 260.40
  • EUR 210.00
  • 100 mg
  • 5 g

PIPES Sodium Salt
20-abx082438
  • EUR 326.40
  • EUR 226.80
  • 250 g
  • 25 g

Carboxymethylcellulose sodium salt
abx082467-100g 100 g
EUR 226.8

Ampicillin Sodium Salt
abx082587-5g 5 g
EUR 210

Sivelestat sodium salt
A4430-10 10 mg
EUR 205.2
Description: Selective leukocyte elastase inhibitor (IC50 = 44 nM) that displays no activity at a range of other proteases. Inhibits NF-?B activation and LTB4-induced neutrophil transmigration in vitro.

Sivelestat sodium salt
A4430-25 25 mg
EUR 408
Description: Selective leukocyte elastase inhibitor (IC50 = 44 nM) that displays no activity at a range of other proteases. Inhibits NF-?B activation and LTB4-induced neutrophil transmigration in vitro.

Sivelestat sodium salt
A4430-5 5 mg
EUR 141.6
Description: Selective leukocyte elastase inhibitor (IC50 = 44 nM) that displays no activity at a range of other proteases. Inhibits NF-?B activation and LTB4-induced neutrophil transmigration in vitro.

Sivelestat sodium salt
A4430-50 50 mg
EUR 673.2
Description: Selective leukocyte elastase inhibitor (IC50 = 44 nM) that displays no activity at a range of other proteases. Inhibits NF-?B activation and LTB4-induced neutrophil transmigration in vitro.

Fostriecin sodium salt
A4536-.1 100 µg
EUR 584.4
Description: IC50: Inhibit protein phosphatase types 2A (PP2A) and 4 (PP4) intensively with an IC50 of 1.5 nM and 3 nM respectively. Inhibit topoisomerase II (Topo II) and protein phosphatase type 1 (PP1) slightly with an IC50 of 40 ?M and 131 ?M respectively.

Fostriecin sodium salt
A4536-.5 500 µg
EUR 1762.8
Description: IC50: Inhibit protein phosphatase types 2A (PP2A) and 4 (PP4) intensively with an IC50 of 1.5 nM and 3 nM respectively. Inhibit topoisomerase II (Topo II) and protein phosphatase type 1 (PP1) slightly with an IC50 of 40 ?M and 131 ?M respectively.

Cefotaxime Sodium Salt
abx188641-100g 100 g
EUR 610.8

Tianeptine Sodium Salt
abx188914-25g 25 g
EUR 376.8

Sulfamerazine sodium salt
B3430-100000 100 g
EUR 164.4
Description: Sulfamerazine Sodium is a sulfonamide antibacterial.

Sulfamerazine sodium salt
B3430-50000 50 g
EUR 132
Description: Sulfamerazine Sodium is a sulfonamide antibacterial.
Scroll to Top